Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
Anja Seckinger(Heidelberg University), Jose Antonio Delgado(Clinica Universidad de Navarra), Samuel Moser(Roche (Switzerland)), Laura Moreno(Clinica Universidad de Navarra), Brigitte Neuber(Heidelberg University), Anna Luise Grab(Heidelberg University), Susanne Lipp(Heidelberg University), Juana Merino(Clinica Universidad de Navarra), Felipe Prósper(Clinica Universidad de Navarra), Martina Emde(Heidelberg University), Camille Delon(Roche (Switzerland)), Melanie Latzko(Roche (Switzerland)), Reto Gianotti(Roche (Switzerland)), Remo Lüoend(Roche (Switzerland)), Ramona Murr(Roche (Switzerland)), Ralf J. Hosse(Roche (Switzerland)), Lydia Jasmin Harnisch(Roche (Switzerland)), Marina Bacac(Roche (Switzerland)), Tanja Fauti(Roche (Switzerland)), Christian Klein(Roche (Switzerland)), Aintzane Zabaleta(Clinica Universidad de Navarra), Jens Hillengaß(Heidelberg University), Elisabetta Ada Cavalcanti‐Adam(Heidelberg University), Anthony D. Ho(Heidelberg University), Michael Hundemer(Heidelberg University), Jesús F. San Miguel(Clinica Universidad de Navarra), K. Strein, Pablo Umaña(Roche (Switzerland)), Dirk Hose(Heidelberg University), Bruno Paiva(Clinica Universidad de Navarra), Minh Diem Vu(DMA Health Strategies)
Cited by 309Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis